Used primarily in medical research, CP-346086 dihydrate functions as an inhibitor of acetyl-CoA carboxylase (ACC), an enzyme involved in fatty acid synthesis and lipid metabolism. Its application is crucial in studying conditions related to cholesterol, lipid disorders, obesity, and type 2 diabetes, providing insights into potential therapeutic strategies. Researchers utilize it to evaluate efficacy and safety, explore metabolic pathways, and assess biochemical impacts that could lead to the development of drugs for managing cardiovascular diseases and other metabolic syndromes. Its role in experimental settings helps in understanding the mechanisms regulating lipid levels and its potential as a future therapeutic agent.